Molecular Partners AG - American Depositary Shares - estatísticas financeiras trimestrais (NASDAQ:MOLN) | MetaTrader

Abrir gráfico completo Full chart

Molecular Partners AG - American Depositary Shares

Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development.

Notícias

Molecular Partners divulga dados de fase 1 para medicamento oncológico MP0317

H.C. Wainwright reitera classificação de compra para Molecular Partners

TD Cowen reitera classificação das ações da Molecular Partners com base no potencial da plataforma de radioligantes

TD Cowen reiterates Molecular Partners stock rating on radioligand platform potential

Will Petrobras Pull Off Q4 Earnings Beat on Strong Production?

Molecular Partners AG (MOLN) Discusses Clinical Imaging and Dosimetry Data for DLL3 Targeting Radiotherapeutic MPO712 Transcript

Ações da Molecular Partners iniciam com classificação de compra na H.C. Wainwright

Molecular Partners stock initiated with Buy rating at H.C. Wainwright

This Visa Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Intuitive Surgical (NASDAQ:ISRG), Mastercard (NYSE:MA)

Molecular Partners AG (MOLN) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:MOLN) 2026-01-19

Molecular Partners AG (MOLN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

EHang, Molecular Partners And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - ECARX Holdings (NASDAQ:ECX), Daqo New Energy (NYSE:DQ)